Marsh & McLennan Companies, Inc. vs Zimmer Biomet Holdings Inc — how do they compare? Marsh & McLennan Companies, Inc. trades at $180.6 (market cap $87.77B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 5.1× Zimmer Biomet Holdings Inc's market cap, and Marsh & McLennan Companies, Inc. pays the higher dividend (2.17%). Which is the better fit depends on your goals.
| MRSH | ZBH | |
|---|---|---|
Market Cap | $87.77B | $17.36B |
Sector | Financials | Health |
52-Week High | $211.21 | $107.71 |
52-Week Low | $157.32 | $79.58 |
Enterprise Value | $108.61B | $24.40B |
Dividend Yield | 2.17% | 1.07% |
Trailing returns across standard periods
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →